Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.
Pérez-Díez A, Liu X, Calderon S, Bennett A, Lisco A, Kellog A, Galindo F, Memoli MJ, Rocco JM, Epling BP, Laidlaw E, Sneller MC, Manion M, Wortmann GW, Poon R, Kumar P, Sereti I. Pérez-Díez A, et al. Among authors: epling bp. Front Immunol. 2024 Apr 17;15:1352330. doi: 10.3389/fimmu.2024.1352330. eCollection 2024. Front Immunol. 2024. PMID: 38694513 Free PMC article.
Immune responses to SARS-CoV-2 mRNA vaccination in people with idiopathic CD4 lymphopenia.
Rocco JM, Boswell KL, Laidlaw E, Epling B, Anderson M, Serebryannyy L, Narpala S, O'Connell S, Kalish H, Kelly S, Porche S, Oguz C, McDermott A, Manion M, Koup RA, Lisco A, Sereti I. Rocco JM, et al. Among authors: epling b. J Allergy Clin Immunol. 2024 Feb;153(2):503-512. doi: 10.1016/j.jaci.2023.10.012. Epub 2023 Oct 28. J Allergy Clin Immunol. 2024. PMID: 38344971
Prolonged Mpox Disease in People With Advanced HIV: Characterization of Mpox Skin Lesions.
O'Shea J, Zucker J, Stampfer S, Cash-Goldwasser S, Minhaj FS, Dretler A, Cheeley J, Chaudhuri S, Gallitano SM, Gunaratne S, Parkinson M, Epling B, Morcock DR, Sereti I, Deleage C. O'Shea J, et al. Among authors: epling b. J Infect Dis. 2024 Mar 26;229(Supplement_2):S243-S248. doi: 10.1093/infdis/jiad532. J Infect Dis. 2024. PMID: 38019806 Free PMC article.
Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment.
Epling BP, Rocco JM, Boswell KL, Laidlaw E, Galindo F, Kellogg A, Das S, Roder A, Ghedin E, Kreitman A, Dewar RL, Kelly SEM, Kalish H, Rehman T, Highbarger J, Rupert A, Kocher G, Holbrook MR, Lisco A, Manion M, Koup RA, Sereti I. Epling BP, et al. Clin Infect Dis. 2023 Feb 18;76(4):573-581. doi: 10.1093/cid/ciac663. Clin Infect Dis. 2023. PMID: 36200701 Free PMC article.
COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavir.
Epling BP, Rocco JM, Boswell KL, Laidlaw E, Galindo F, Kellogg A, Das S, Roder A, Ghedin E, Kreitman A, Dewar RL, Kelly SEM, Kalish H, Rehman T, Highbarger J, Rupert A, Kocher G, Holbrook MR, Lisco A, Manion M, Koup RA, Sereti I. Epling BP, et al. medRxiv [Preprint]. 2022 Jun 17:2022.06.16.22276392. doi: 10.1101/2022.06.16.22276392. medRxiv. 2022. PMID: 35734093 Free PMC article. Updated. Preprint.
Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task.
Nunes EJ, Randall PA, Estrada A, Epling B, Hart EE, Lee CA, Baqi Y, Müller CE, Correa M, Salamone JD. Nunes EJ, et al. Among authors: epling b. Psychopharmacology (Berl). 2014 Feb;231(4):727-36. doi: 10.1007/s00213-013-3285-4. Epub 2013 Oct 18. Psychopharmacology (Berl). 2014. PMID: 24136220 Free PMC article.
11 results